Two Sigma Advisers
CRBP icon

Two Sigma Advisers’s Corbus Pharmaceuticals CRBP Stock Holding History

Two Sigma Advisers’s Portfolio CRBP Stock Details CRBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-16,340
Closed -$113K – 2400
2025
Q2 		$113K Sell
16,340
-19,800
-55% -$144K ﹤0.01% 2197
2025
Q1 		$192K Buy
36,140
+25,113
+228% +$222K ﹤0.01% 2146
2024
Q4 		$130K Buy
+11,027
New +$185K ﹤0.01% 2187
2022
Q4 		– Sell
-560
Closed -$3K – 2544
2022
Q3 		$3K Buy
+560
New +$3.95K ﹤0.01% 2509
2022
Q2 		– Sell
-467
Closed -$7K – 2692
2022
Q1 		$7K Buy
467
+90
+24% +$1.19K ﹤0.01% 2706
2021
Q4 		$7K Buy
+377
New +$10.2K ﹤0.01% 2583
2021
Q3 		– Sell
-1,333
Closed -$73K – 2474
2021
Q2 		$73K Sell
1,333
-7,620
-85% -$423K ﹤0.01% 2365
2021
Q1 		$529K Buy
8,953
+7,416
+482% +$487K ﹤0.01% 2004
2020
Q4 		$58K Buy
+1,537
New +$57.5K ﹤0.01% 2307
2020
Q3 		– Sell
-1,737
Closed -$437K – 2435
2020
Q2 		$437K Buy
+1,737
New +$351K ﹤0.01% 1953
2020
Q1 		– Sell
-447
Closed -$73K – 2476
2019
Q4 		$73K Sell
447
-260
-37% -$38.4K ﹤0.01% 2273
2019
Q3 		$103K Buy
+707
New +$123K ﹤0.01% 2112

Other funds holding CRBP

CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
EAM
Exome Asset Management New York $193M AUM 208.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Comerica Bank
Comerica Bank Dallas, Texas $25.1B AUM 24.68% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

Two Sigma Advisers's CRBP Position: Q3 2025 in Review

Two Sigma Advisers sold out of Corbus Pharmaceuticals (CRBP) in Q3 2025, closing a stake of 16,340 shares — an estimated $113K sold.

Two Sigma Advisers first reported a position in CRBP in Q3 2019 and held it in 12 quarters. The position peaked at $529K in Q1 2021. 81 funds tracked by Wall St. Rank hold CRBP as of Q3 2025.

  • Two Sigma Advisers reported no remaining Corbus Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • Two Sigma Advisers sold 16,340 Corbus Pharmaceuticals shares in Q3 2025, an estimated $113K.
  • Two Sigma Advisers first reported a position in Corbus Pharmaceuticals in Q3 2019 and held it in 12 quarters.
  • Two Sigma Advisers's Corbus Pharmaceuticals position peaked at $529K in Q1 2021.
  • 81 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q3 2025.

Based on Two Sigma Advisers's 13F filing for Q3 2025, filed 14 Nov 2025.